載入...
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic protein are elevated in diabetes and insulin resista...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003717/ https://ncbi.nlm.nih.gov/pubmed/33804680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22063170 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|